Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Adverse drug events in pediatric outpatients.

Adverse drug events in pediatric outpatients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Adverse drug events in pediatric outpatients. Abstract Text:

    rainu kaushalRainu Kaushal,donald a goldmannDonald A Goldmann,carol a keohaneCarol A Keohane,melissa christinoMelissa Christino,melissa honourMelissa Honour,andrea s haleAndrea S Hale,katherine zigmontKatherine Zigmont,lisa soleymani lehmannLisa Soleymani Lehmann,james perrinJames Perrin,david w batesDavid W Bates,rainu kaushalRainu Kaushal,donald a goldmannDonald A Goldmann,carol a keohaneCarol A Keohane,melissa christinoMelissa Christino,melissa honourMelissa Honour,andrea s haleAndrea S Hale,katherine zigmontKatherine Zigmont,lisa soleymani lehmannLisa Soleymani Lehmann,james perrinJames Perrin,david w batesDavid W Bates,

    OBJECTIVE: To determine rates and types of adverse drug events (ADEs) in the pediatric ambulatory setting. METHODS: A prospective cohort study at 6 office practices in the greater Boston area was conducted over 2-month periods. Duplicate prescription review, telephone surveys 10 days and 2 months after visit, and chart reviews were done. A 2-physician panel classified the severity, preventability, and ability to ameliorate (ie, if the severity or duration of the side effect could have been mitigated by improved communication) ADEs. RESULTS: We identified 57 preventable ADEs (rate 3%; 95% confidence intervals [CI], 3%-4%) and 226 nonpreventable ADEs (rate 13%; 95% CI, 11%-15%) in the medical care of 1788 patients. Of the ADEs, 152 (54%) were able to be ameliorated. None of the preventable ADEs were life threatening, although 8 (14%) were serious. Forty (70%) of the preventable ADEs were related to parent drug administration. Improved communication between health care providers and parents and improved communication between pharmacists and parents, whether in the office or in the pharmacy, were judged to be the prevention strategies with greatest potential. CONCLUSIONS: Patient harm from medication use was common in the pediatric ambulatory setting. Errors in home medication administration resulted in the majority of preventable ADEs. Approximately one fifth of ADEs were potentially preventable and many more were potentially able to be ameliorated. Rates of ADEs due to errors are comparable in children and adults despite less medication utilization in children.

    Adverse drug events in pediatric outpatients. Publishing Authors By Initials

    r kaushalR Kaushal,da goldmannDA Goldmann,ca keohaneCA Keohane,m christinoM Christino,m honourM Honour,as haleAS Hale,k zigmontK Zigmont,ls lehmannLS Lehmann,j perrinJ Perrin,dw batesDW Bates,r kaushalR Kaushal,da goldmannDA Goldmann,ca keohaneCA Keohane,m christinoM Christino,m honourM Honour,as haleAS Hale,k zigmontK Zigmont,ls lehmannLS Lehmann,j perrinJ Perrin,dw batesDW Bates,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE: 2007 Sep-Oct

    Adverse drug events in pediatric outpatients. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Ambulatory pediatrics : the official journal of th

    VOLUME: 7

    Page Numbers: 383-9

    Journal Abbreviation:

    ISSN: 1530-1567

    DAY: 17

    MONTH: 09

    YEAR: 2007

    Adverse drug events in pediatric outpatients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101089367

    Adverse drug events in pediatric outpatients. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Adverse drug events in pediatric outpatients. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Adverse drug events in pediatric outpatients.

    AFFILIATION: Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. rkaushal@partners.org

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States AHRQ

    GRANT: 5 P01 HS11534-04

    ACRONYM: HS

    MEDLINETA: Ambul Pediatr

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Adverse drug events in pediatric outpatients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News